MGH Center for Women's Mental Health

About MGH Center for Women's Mental Health

This author has not yet filled in any details.
So far MGH Center for Women's Mental Health has created 1461 blog entries.

Weekly Roundup for JUNE 15, 2018: Recent Publications in Women’s Mental Health

Each week, we take a quick look at the most recent articles published in women's mental health. Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric [...]

By |2018-06-25T02:07:21-04:00June 16th, 2018|Weekly Roundup|Comments Off on Weekly Roundup for JUNE 15, 2018: Recent Publications in Women’s Mental Health

Brexanolone: A New Drug for Postpartum Depression

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression (PPD).  SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors.  This drug was initially [...]

By |2018-06-15T11:29:21-04:00June 11th, 2018|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Brexanolone: A New Drug for Postpartum Depression

Predictors for New-Onset Severe Postpartum Psychiatric Disorders

A history of maternal psychiatric illness has been linked to postpartum depression (PPD), but this does not account for all instances of postpartum psychiatric illness. A recent study examined the impact of medical complications during [...]

By |2018-06-08T19:24:47-04:00June 8th, 2018|Postpartum Psychiatric Disorders|Comments Off on Predictors for New-Onset Severe Postpartum Psychiatric Disorders

Breastfeeding and Marijuana: What’s Safe?

We continue to see more and more women of reproductive age using marijuana in various forms.  According to research published in the Journal of the American Medical Association, there has been a significant increase in [...]

By |2018-10-03T22:46:11-04:00May 23rd, 2018|Breastfeeding & Medications, Cannabis, Outcomes, Perinatal Substance Use|Comments Off on Breastfeeding and Marijuana: What’s Safe?

Fluvoxamine and Pregnancy: Is There a Right Choice?

  Every day, we see women in our clinic who are deciding whether to continue a selective serotonin reuptake inhibitor (SSRI) for management of depression or anxiety during pregnancy. As a class, SSRI use during [...]

By |2018-09-10T12:34:17-04:00May 16th, 2018|Antidepressants, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Fluvoxamine and Pregnancy: Is There a Right Choice?

United Kingdom Limits the Use of Valproate in Reproductive Age Women

  Last year France banned the use of the antiepileptic during valproate in certain populations of reproductive age women.  Now the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) has banned the use of [...]

By |2018-09-10T12:34:17-04:00May 9th, 2018|Anti-Epileptic Drugs, Pregnancy & Medications|Comments Off on United Kingdom Limits the Use of Valproate in Reproductive Age Women
Go to Top